IAG
KLRS

Investmark Advisory Group’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Investmark Advisory Group’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-9
Closed -$2K – 372
2021
Q4 		$2K Buy
+9
New +$2K ﹤0.01% 359